EUVIMEDDescoperă EUVIMED
Open access · CC BY-NC-ND 4.0

Bioprocess development for cord blood mesenchymal stromal cells on microcarriers in Vertical‐Wheel bioreactors

Erin L Roberts, Sarah I M Lepage, Thomas G Koch, Michael S Kallos iD

Biotechnology and Bioengineering · 2024

DOI: 10.1002/bit.28557 ↗

At a glance

Journal article in Biotechnology and Bioengineering, 2024. Written by Erin L Roberts and 3 co-authors. Institution: Pharmaceutical Production Research Facility, Schulich School of Engineering, University of Calgary, Calgary, Alberta, Canada. Major MEDLINE topics: Cell Culture Techniques, Mesenchymal Stem Cells. Cited 3 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Ontario Agri-Food Innovation Alliance, Natural Sciences and Engineering Research Council of Canada.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Equine mesenchymal stromal cells (MSCs) have been found to be beneficial for the treatment of many ailments, including orthopedic injuries, due to their superior differentiation potential and immunomodulating properties. Cell therapies require large cell numbers, which are not efficiently generated using conventional static expansion methods. Expansion of equine cord blood‐derived MSCs (eCB‐MSCs) in bioreactors, using microcarriers as an attachment surface, has the potential to generate large numbers of cells with increased reproducibility and homogeneity compared with static T‐flask expansion. This study investigated the development of an expansion process using Vertical‐Wheel (VW) bioreactors, a single‐use bioreactor technology that incorporates a wheel instead of an impeller. Initially, microcarriers were screened at small scale to assess eCB‐MSC attachment and growth and then in bioreactors to assess cell expansion and harvesting. The effect of different donors, serial passaging, and batch versus fed batch were all examined in 0.1 L VW bioreactors. The use of VW bioreactors with an appropriate microcarrier was shown to be able to produce cell densities of up to 1E6 cells/mL, while maintaining cell phenotype and functionality, thus demonstrating great potential for the use of these bioreactors to produce large cell numbers for cell therapies.

Subjects

MeSH terms (MEDLINE)

Cell Culture TechniquesMesenchymal Stem CellsAnimalsHorsesFetal BloodReproducibility of ResultsBioreactorsCell DifferentiationCell Proliferation

Author keywords

biomanufacturingbioreactormesenchymal stromal cellsmicrocarrierscale-up

Authors and institutions

  • Pharmaceutical Production Research Facility, Schulich School of Engineering, University of Calgary, Calgary, Alberta, Canada.
  • Department of Biomedical Engineering, Schulich School of Engineering, University of Calgary, Calgary, Alberta, Canada.
  • Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.

ORCID profiles: Michael S Kallos

Funding

  • Ontario Agri-Food Innovation Alliance
  • Natural Sciences and Engineering Research Council of Canada

Cite

APA

Roberts, E. L., Lepage, S. I. M., Koch, T. G., & Kallos, M. S. (2024). Bioprocess development for cord blood mesenchymal stromal cells on microcarriers in Vertical‐Wheel bioreactors. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28557

Vancouver

Roberts EL, Lepage SIM, Koch TG, Kallos MS. Bioprocess development for cord blood mesenchymal stromal cells on microcarriers in Vertical‐Wheel bioreactors. Biotechnology and Bioengineering. 2024. doi:10.1002/bit.28557

BibTeX
@article{Roberts2024,
  author = {Roberts, Erin L and Lepage, Sarah I M and Koch, Thomas G and Kallos, Michael S},
  title = {Bioprocess development for cord blood mesenchymal stromal cells on microcarriers in Vertical‐Wheel bioreactors},
  journal = {Biotechnology and Bioengineering},
  year = {2024},
  doi = {10.1002/bit.28557}
}
Start for free →